Accordingly, the recent ENGAGE-HD (ISRCTN65378754) and PACE-HD (NCT03344601) clinical trials employed physical activity interventions in HD individuals but did not evaluate BDNF expression as primary or secondary measures of interest. Here, BDNF is linked to Huntington disease.